Mechanisms of Resistance to Antibacterial Agents in Staphylococcus and Enterococcus
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".
Deadline for manuscript submissions: closed (15 March 2024) | Viewed by 339
Special Issue Editor
Interests: antimicrobial resistance (AMR); biofilm; environmental response; molecular genetics; bacterial pathogenicity; infection control
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Staphylococcus and Enterococcus are Gram-positive cocci that are recognized as globally important opportunistic pathogens that can cause serious infections in humans, especially in hospitalized patients. Over recent decades, there has been a significant increase in the rates of acquired antimicrobial resistance (AMR) in these species, either through the acquisition of resistance determinants by horizontal gene transfer of mobile genetic elements (MGEs), or through mutations that alter gene expression or binding sites in native genes. This has resulted in the emergence of polyclonal lineages that are resistant to front-line therapeutic agents.
Understanding more about these mechanisms should hopefully lead to better treatment options, and the development of antimicrobial drugs that can withstand the microorganisms' attempts to become resistant. Our Special Issue seeks to compile leading-edge research that unravels the intricate tapestry of resistance mechanisms within Staphylococcus and Enterococcus. This Special Issue considers all aspects of antibiotic resistance in Staphylococcus and Enterococcus, illuminating the molecular underpinnings of resistance and providing insights into strategies to counteract these mechanisms. Manuscripts exploring genetic determinants, plasmid-mediated resistance dissemination, and the role of mobile genetic elements in resistance propagation are highly encouraged.
Dr. Hidetada Hirakawa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- drug resistance
- infection control
- gene transfer
- methicillin-resistant Staphylococcus aureus (MRSA)
- vancomycin-resistant enterococci (VRE)
- whole-genome analysis (WGS)
